BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11836714)

  • 21. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.
    Megonigal MD; Rappaport EF; Wilson RB; Jones DH; Whitlock JA; Ortega JA; Slater DJ; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9597-602. PubMed ID: 10920186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of common chromosomal translocations in small round blue cell pediatric tumors.
    Ponce-Castañeda MV; García-Chéquer AJ; Eguía Aguilar P; Abundes-Ramírez MA; Hernández-Angeles A; Nieto-Martínez K; Gómez-Laguna L; Sadowinski-Pine S; Cabrera-Muñoz Mde L
    Arch Med Res; 2014 Feb; 45(2):143-51. PubMed ID: 24486246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma.
    Nordberg J; Mpindi JP; Iljin K; Pulliainen AT; Kallajoki M; Kallioniemi O; Elenius K; Elenius V
    PLoS One; 2012; 7(12):e50819. PubMed ID: 23227212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation.
    Johnstone PA; Wexler LH; Venzon DJ; Jacobson J; Yang JC; Horowitz ME; DeLaney TF
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):735-45. PubMed ID: 8040019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele.
    Iwami K; Shimato S; Ohno M; Okada H; Nakahara N; Sato Y; Yoshida J; Suzuki S; Nishikawa H; Shiku H; Natsume A; Wakabayashi T
    Cytotherapy; 2012 Jul; 14(6):733-42. PubMed ID: 22424217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.
    Cohen-Gogo S; Cellier C; Coindre JM; Mosseri V; Pierron G; Guillemet C; Italiano A; Brugières L; Orbach D; Laurence V; Delattre O; Michon J
    Pediatr Blood Cancer; 2014 Dec; 61(12):2191-8. PubMed ID: 25176412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.
    Folpe AL; Goldblum JR; Rubin BP; Shehata BM; Liu W; Dei Tos AP; Weiss SW
    Am J Surg Pathol; 2005 Aug; 29(8):1025-33. PubMed ID: 16006796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
    Rüttinger D; van den Engel NK; Winter H; Schlemmer M; Pohla H; Grützner S; Wagner B; Schendel DJ; Fox BA; Jauch KW; Hatz RA
    J Transl Med; 2007 Sep; 5():43. PubMed ID: 17868452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.
    de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR
    Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma.
    Krishnadas DK; Shusterman S; Bai F; Diller L; Sullivan JE; Cheerva AC; George RE; Lucas KG
    Cancer Immunol Immunother; 2015 Oct; 64(10):1251-60. PubMed ID: 26105625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.
    Hill DA; O'Sullivan MJ; Zhu X; Vollmer RT; Humphrey PA; Dehner LP; Pfeifer JD
    Am J Surg Pathol; 2002 Aug; 26(8):965-77. PubMed ID: 12170083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
    Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
    J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas.
    Pappo AS; Dirksen U
    J Clin Oncol; 2018 Jan; 36(2):168-179. PubMed ID: 29220292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.